{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:54:00Z","timestamp":1769010840316,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bcp.2021.114738","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:32:31Z","timestamp":1629333151000},"page":"114738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The C-terminal cleavage of angiotensin II and III is mediated by prolyl carboxypeptidase in human umbilical vein and aortic endothelial cells"],"prefix":"10.1016","volume":"192","author":[{"given":"Emilie","family":"De Hert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Bracke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Lambeir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Van der Veken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5148","key":"10.1016\/j.bcp.2021.114738_b0005","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/2181224a0","article-title":"New enzymatic route for the inactivation of angiotensin","volume":"218","author":"YANG","year":"1968","journal-title":"Nature."},{"issue":"22","key":"10.1016\/j.bcp.2021.114738_b0010","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/0024-3205(83)90285-0","article-title":"Prolyl endopeptidase","volume":"33","author":"Wilk","year":"1983","journal-title":"Life Sci."},{"issue":"17","key":"10.1016\/j.bcp.2021.114738_b0015","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114738_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1471-4159.1983.tb11815.x","article-title":"Inhibition of Rabbit Brain Prolyl Endopeptidase by N-Benzyloxycarbonyl-Prolyl-Prolinal, a Transition State Aldehyde Inhibitor","volume":"41","author":"Wilk","year":"1983","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.bcp.2021.114738_b0025","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0968-0896(02)00061-5","article-title":"4-Phenylbutanoyl-2(S)-acylpyrrolidines and 4-Phenylbutanoyl-L-prolyl-2(S)-acylpyrrolidines as Prolyl Oligopeptidase Inhibitors","volume":"10","author":"Wall\u00e9n","year":"2002","journal-title":"Bioorganic Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114738_b0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ab.2013.09.002","article-title":"Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements","volume":"443","author":"Kehoe","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2021.114738_b0035","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2003-07-2510","article-title":"Recombinant prolylcarboxypeptidase activates plasma prekallikrein","volume":"103","author":"Shariat-Madar","year":"2004","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.bcp.2021.114738_b0040","doi-asserted-by":"crossref","first-page":"E1016","DOI":"10.1152\/ajpendo.00515.2011","article-title":"Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney","volume":"302","author":"Grobe","year":"2012","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2021.114738_b0045","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00087.2012","article-title":"Enzymatic processing of angiotensin peptides by human glomerular endothelial cells","volume":"302","author":"Velez","year":"2012","journal-title":"Am. J. Physiol. - Ren. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114738_b0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.healun.2016.08.022","article-title":"Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients","volume":"36","author":"Kovarik","year":"2017","journal-title":"J. Hear. Lung Transplant."},{"issue":"10","key":"10.1016\/j.bcp.2021.114738_b0055","doi-asserted-by":"crossref","first-page":"C945","DOI":"10.1152\/ajpcell.00346.2012","article-title":"Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry","volume":"304","author":"Grobe","year":"2013","journal-title":"Am. J. Physiol. - Cell Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114738_b0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/HYPERTENSIONAHA.119.14071","article-title":"Ang II (Angiotensin II) Conversion to Angiotensin-(1\u20137) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent","volume":"75","author":"Serfozo","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.bcp.2021.114738_b0065","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2021.01.052","article-title":"Myocardial Angiotensin Metabolism in End-Stage Heart Failure","volume":"77","author":"Pavo","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2021.114738_b0070","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacc.2021.05.034","article-title":"Use of Nonspecific Protease Inhibitors in Research: An Underestimated Problem","volume":"78","author":"De Hert","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114738_b0075","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1021\/jm101013m","article-title":"Design and synthesis of prolylcarboxypeptidase (PrCP) inhibitors to validate PrCP as a potential target for obesity","volume":"53","author":"Zhou","year":"2010","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2021.114738_b0080","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/S0021-9258(17)34557-X","article-title":"Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney","volume":"253","author":"Odya","year":"1978","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114738_b0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1470320312474854","article-title":"Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems","volume":"15","author":"Su","year":"2014","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"19","key":"10.1016\/j.bcp.2021.114738_b0090","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/0006-2952(87)90631-9","article-title":"Kinin and angiotensin metabolism by purified renal post-proline cleaving enzyme","volume":"36","author":"Ward","year":"1987","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114738_b0095","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1074\/jbc.M212934200","article-title":"Novel peptide inhibitors of angiotensin-converting enzyme 2","volume":"278","author":"Huang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2021.114738_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bcp.2005.11.029","article-title":"Binding kinetics and duration of in vivo action of novel prolyl oligopeptidase inhibitors","volume":"71","author":"Ven\u00e4l\u00e4inen","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114738_b0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuint.2011.12.010","article-title":"The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum","volume":"60","author":"Jalkanen","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2021.114738_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22136698","article-title":"Prolyl carboxypeptidase mediates the C-terminal cleavage of (Pyr)-apelin-13 in human umbilical vein and aortic endothelial cells","volume":"22","author":"De Hert","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3-4","key":"10.1016\/j.bcp.2021.114738_b0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cca.2011.10.031","article-title":"Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors","volume":"413","author":"Matheeussen","year":"2012","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.bcp.2021.114738_b0120","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","article-title":"A prolyl oligopeptidase inhibitor, KYP-2047, reduces \u03b1-synuclein protein levels and aggregates in cellular and animal models of Parkinson\u2019s disease","volume":"166","author":"My\u00f6h\u00e4nen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114738_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.11.008","article-title":"Prolyl oligopeptidase inhibition attenuates the toxicity of a proteasomal inhibitor, lactacystin, in the alpha-synuclein overexpressing cell culture","volume":"636","author":"My\u00f6h\u00e4nen","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2021.114738_b0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/rcm.3444","article-title":"mMass data miner: an open source alternative for mass spectrometric data analysis","volume":"22","author":"Strohalm","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.bcp.2021.114738_b0135","first-page":"219","article-title":"Ligand-induced conformational changes in prolyl oligopeptidase: A kinetic approach","volume":"30","author":"Van Elzen","year":"2017","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bcp.2021.114738_b0140","first-page":"1481","article-title":"Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme","volume":"2016","author":"Kehoe","year":"1864","journal-title":"Biochim. Biophys. Acta - Proteins Proteomics."},{"key":"10.1016\/j.bcp.2021.114738_b0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0006-2952(70)90380-1","article-title":"Characteristics of an enzyme that inactivates angiotensin II (Angiotensinase C)","volume":"19","author":"Yang","year":"1970","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114738_b0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbrc.2010.12.036","article-title":"Highly selective hydrolysis of kinins by recombinant prolylcarboxypeptidase","volume":"405","author":"Chajkowski","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114738_b0155","first-page":"255","article-title":"Purification of aminopeptidase a in human serum and degradation of angiotensin II by the purified enzyme","volume":"198","author":"Nagatsu","year":"1970","journal-title":"BBA - Enzymol."},{"key":"10.1016\/j.bcp.2021.114738_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2019.104558","article-title":"Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A","volume":"151","author":"Svarcbahs","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.bcp.2021.114738_b0165","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1074\/jbc.M106101200","article-title":"Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator","volume":"277","author":"Shariat-Madar","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221003543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:08:27Z","timestamp":1762096107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221003543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":33,"alternative-id":["S0006295221003543"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114738","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The C-terminal cleavage of angiotensin II and III is mediated by prolyl carboxypeptidase in human umbilical vein and aortic endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114738"}}